Tech Company Financing Transactions
Cresilon Funding Round
Cresilon closed a $25 million Series A funding round on 10/27/2022. Backers included Paulson & Co. and private investors.
Transaction Overview
Company Name
Announced On
10/27/2022
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
Paulson & Co. (Lead Investor) (Thomas Parigian)
Proceeds Purpose
The financing will be used to accelerate Cresilon's global growth plan, increase production capacity at its state-of-the-art biomanufacturing facility in Brooklyn, and expand upon the company's successful launch of VETIGEL®, the first hemostatic gel for the animal health market that instantly stops bleeding in a wide variety of applications including emergency care and surgical procedures.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
122 18th St.
Brooklyn, NY 11215
USA
Brooklyn, NY 11215
USA
Phone
Website
Email Address
Overview
Constantly experimenting with natural materials in the lab as a young adult, Joe Landolina developed an adhesive hemostatic gel composed of plant-based polymers that could support the natural clotting process.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joe Landolina
Executive Vice President
Isaac Miller
Browse more venture capital transactions:
Prev: 10/27/2022: Ninetailed venture capital transaction
Next: 10/27/2022: HealthJoy venture capital transaction
Share this article
News on VC Transactions
We do our best to record funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs